Correlation Between ImmunoCellular Therapeutics and Better Therapeutics
Can any of the company-specific risk be diversified away by investing in both ImmunoCellular Therapeutics and Better Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoCellular Therapeutics and Better Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmunoCellular Therapeutics and Better Therapeutics, you can compare the effects of market volatilities on ImmunoCellular Therapeutics and Better Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoCellular Therapeutics with a short position of Better Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoCellular Therapeutics and Better Therapeutics.
Diversification Opportunities for ImmunoCellular Therapeutics and Better Therapeutics
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ImmunoCellular and Better is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoCellular Therapeutics and Better Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Better Therapeutics and ImmunoCellular Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoCellular Therapeutics are associated (or correlated) with Better Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Better Therapeutics has no effect on the direction of ImmunoCellular Therapeutics i.e., ImmunoCellular Therapeutics and Better Therapeutics go up and down completely randomly.
Pair Corralation between ImmunoCellular Therapeutics and Better Therapeutics
If you would invest 73.00 in Better Therapeutics on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Better Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ImmunoCellular Therapeutics vs. Better Therapeutics
Performance |
| Timeline |
| ImmunoCellular Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Better Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ImmunoCellular Therapeutics and Better Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ImmunoCellular Therapeutics and Better Therapeutics
The main advantage of trading using opposite ImmunoCellular Therapeutics and Better Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoCellular Therapeutics position performs unexpectedly, Better Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Better Therapeutics will offset losses from the drop in Better Therapeutics' long position.The idea behind ImmunoCellular Therapeutics and Better Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Better Therapeutics vs. ABVC Biopharma | Better Therapeutics vs. Indaptus Therapeutics | Better Therapeutics vs. Pasithea Therapeutics Corp | Better Therapeutics vs. Forte Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |